• OVERVIEW
• MANAGEMENT
• BOARD OF DIRECTORS
  • KABAKOFF
  • STEIN
  • POWELL
  • ATWOOD
  • KJELLSON
  • O'LEARY
  • STACK
• CLINICAL ADVISORY BOARD
• BUSINESS ADVISORY BOARD

Brian Atwood,

is a Managing Director of Versant Ventures where he specializes in biotechnology investing. He co-founded Versant Ventures after spending four years at Brentwood Venture Capital where he was a General Partner. Prior to launching his career in venture capital, Mr. Atwood was founder, president, and CEO of Glycomed, a publicly traded biotechnology company. He led the sale of Glycomed to Ligand Pharmaceuticals. Prior to this, he co-founded and served as director of Perkin Elmer/Cetus Instruments, a joint venture for robotics automation and genomics research instruments and products later acquired by Perkin Elmer. Mr. Atwood received a Bachelor's degree in Biological Sciences from the University of California, Irvine, a Master's degree from the University of California, Davis, and an MBA from Harvard Business School.